Skip to content

Investor Relations / Publications / Cardiovascular Outcomes Trials

Cardiovascular Outcomes Trials

To search publications using the available search words, please click here:

Boden WE, Bhatt DL, Toth PP, et al. Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics. Eur Heart J. 2020;41(24):2304–2312.

Amarin Corporation